BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30

• BioCapital

  FDA Issues New Dosing Guide for Children Using Genentech’s Valcyte

  September 16, 2010

   · 

  2 min read
• Biotech Beach

  AVANIR Pharmaceuticals to Present at the UBS Global Life Sciences Conference

  September 16, 2010

   · 

  1 min read
• Genetown

  TetraPhase Pharmaceuticals to Present at UBS 2010 Global Life Sciences Conference

  September 16, 2010

   · 

  1 min read
• Business

  ImmunoCellular Therapeutics, Ltd Selects Averion International Corp. to Conduct Phase II Glioblastoma Study

  September 16, 2010

   · 

  1 min read
• Genetown

  New England Biolabs, Inc. Receives Award to Develop Novel Enzymatic Reagents for Epigenetic Studies

  September 16, 2010

   · 

  2 min read
• Business

  Len DeBenedictis Retires as Chief Technology Officer of Solta Medical, Inc.

  September 16, 2010

   · 

  1 min read
• Business

  Itero Biopharmaceuticals Appoints Debanjan Ray to Vice President, Business Development

  September 16, 2010

   · 

  1 min read
• Business

  Pharma Lynx Signs MSA with NewCardio for Phase 1 QT Studies using QTinno

  September 16, 2010

   · 

  6 min read
• Pharm Country

  NMS Labs Now Performs Urine Tests for Metabolites of Synthetic Cannabinoids Found in K2 and Spice

  September 16, 2010

   · 

  1 min read
• Drug Development

  Phase I/II Data Published in New England Journal of Medicine Demonstrate that Incyte Corporation JAK Inhibitor, INCB18424, Provides Marked and Durable Clinical Benefits in Patients with Myelofibrosis, a Rare, Life-Threatening Blood Cancer

  September 16, 2010

   · 

  1 min read